Baxter

Baxter is a top pharmaceutical company based in Deerfield, Illinois, USA

Baxter is a top pharmaceutical company based in Deerfield, Illinois, USA.Baxter International was founded in 1931 by Donald Baxter, a medical doctor, as a manufacturer and distributor of intravenous therapy solutions.

Baxter is a global healthcare company with expertise in medical devices, pharmaceuticals and biotechnology.

Baxter is a top pharmaceutical company based in Deerfield, Illinois, USA.

Baxter International was founded in 1931 by Donald Baxter, a medical doctor, as a manufacturer and distributor of intravenous therapy solutions.

Baxter is a global healthcare company with expertise in medical devices, pharmaceuticals and biotechnology.

The company has two core businesses; both focused on advancing innovations that provide better options and outcomes, enabling healthier lives.

BioScience– Baxter is a leading manufacturer of therapies for various diseases and treatment areas:

  • Recombinant and plasma-based proteins: Haemophilia and other bleeding disorders;
  • Plasma-based therapies:  Immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions;
  • Products for regenerative medicine: Biosurgery products, Vaccines.

Medical products– Baxter’s Medical Products business manufactures products used in the delivery of fluids and drugs to patients. These include:

  • Intravenous (IV) solutions and administration sets,
  • Premixed drugs and drug-reconstitution systems,
  •  IV nutrition products,
  • Infusion pumps
  • Inhalation anaesthetics.

Baxter's Medical Products business is a leader in Renal home-based therapies, such as peritoneal dialysis.

Baxter has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Baxter has a long history of partnering, building numerous collaborative partnerships.

Baxter announced over 73 partnering / licensing deals since 2005, most of which were signed during the year 2007. Analysis of the partnering deals shows a strong emphasis on partnerships in kidney and peritoneal diseases , haemophilia, cardiovascular, cancer, followed by infectives, central nervous system, genitourinary and metabolic diseases more

Baxter has also announced 6 M&A deals since 2005, with the lead deals being the acquisition of Prism Pharmaceuticals in April 2011 more

Report: Partnering Deals and Alliances with Baxter Healthcare

Examples of recent partnering and licensing deals announced by Baxter can be viewed in Current Partnering's Partnering Agreements with Baxter 2005-2013 partnering activity review article.

Examples of recent M&A deals announced by Baxter can be viewed in Current Partnering's : Partnering Deals and Alliances with Baxter Healthcare M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Baxter Healthcare

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Baxter Healthcare

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Baxter

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Baxter company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email